HEARTWARE, INC. HEARTWARE VENTRICULAR ASSIST SYSTEM - PUMP; VENTRICULAR (ASSISST) BYPASS
|
Back to Search Results |
|
Model Number 1103 |
Device Problems
Obstruction of Flow (2423); Deformation Due to Compressive Stress (2889); Pumping Problem (3016)
|
Patient Problems
Bacterial Infection (1735); High Blood Pressure/ Hypertension (1908); Thrombosis/Thrombus (4440)
|
Event Date 11/27/2023 |
Event Type
Injury
|
Manufacturer Narrative
|
investigation of this event is pending and a supplemental report will be sent upon its completion.Additional products: d1: heartware ventricular assist system ¿ outflow graft, d4: model #: 1125, catalog #: 1125, expiration date: 31-oct-2022, serial or lot#: (b)(6), udi #: (b)(4).D9: no.H3: no.H4: mfg date: 01-oct-2017.H5: yes.H6: the codes present in section h6 correspond to components/products that comprise the reported event.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.
|
|
Event Description
|
It was reported that the patient's international normalized ratio (inr) was subtherapeutic at 1.3, so the patient was admitted for a nticoagulation bridging.It was also noted that the ventricular assist device (vad) exhibited low flows which were attributed to the patient's hypertension.The patient also had persistent bacteremia (faecalis methicillin-sensitive staphylococcus aureus) and staphylococcus epidermidis.The patient was started on antibiotics, which subsequently had to be switched to another antibiotic due to the patient developing a rash.A computerized tomography (ct) scan of the chest, abdomen and pelvis was negative for abscess and infection.However, it showed severe stenosis of the outflow graft which was read as a thrombus, so the patient was treated with heparin.It was stated that there was external compression of the stenosis.A transesophageal echocardiogram (tee) was also performed and was negative for endocarditis and indicated an ejection fraction of 60 percent.The vad and outflow graft remain in use. no further patient complications have been reported as a result of this event.
|
|
Manufacturer Narrative
|
A supplemental report is being submitted for investigation completion.Product event summary: the ventricular assist device (vad) (b)(6) and the associated outflow graft (lot 17058548-0604) were not returned for evaluation.Log file analysis could not be performed since log files were not available for analysis.As a result, the reported low flow event could not be confirmed.Based on the available information, the device may have caused or contributed to the reported event.Based on the risk documentation, possible causes of the reported low flow event may be attributed to multiple factors including but not limited to thrombus at the inflow cannula/outflow graft, constriction at the outflow graft, poor vad filling, and/or inappropriate pump rotational speed.Per the instructions for use, thrombus, infection and hypertension are known potential complications associated with the implantation of a vad.Based on review of past adverse events for this patient, it was noted that the patient had a history of thrombus and infection.Possible clinical factors that may have contributed to this event include the patient¿s pre-existing history and related comorbidities, the progression of their underlying disease, issues related to the therapeutic use of anticoagulant and antiplatelet medications and the patient's complex post-operative course.There are possible patient, pharmacological and procedural factors that may have contributed to this event.Additional products: d1: out flow graft d4: lot#: 17058548-0604 h6: the codes present in section h6 correspond to components/products that comprise the reported event.Investigation of this event is completed and the file will be closed.If new information is received, the file will be re-opened and a supplemental will be submitted.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
|
Search Alerts/Recalls
|
|
|